Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial-Reference-Cited by-同舟云学术

Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial

Published:2017-09 Issue:9 Volume:112 Page:1374-1381
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Hsu Ping-I,Tsai Feng-Woei,Kao Sung-Shuo,Hsu Wen-Hung,Cheng Jin-Shiung,Peng Nan-Jing,Tsai Kuo-Wang,Hu Huang-Ming,Wang Yao-Kuang,Chuah Seng-Kee,Chen Angela,Wu Deng-Chyang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. Helicobacter pylori infection.;Suerbaum;N Engl J Med,2002

2. Peptic ulcer disease.;Malfertheiner;Lancet,2009

3. Antibacterial treatment of gastric ulcer associated with Helicobacter pylori.;Sung;N Eng J Med,1995

4. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomized controlled trials.;Ford;BMJ,2014

5. Low eradication rate of Helicobacter pylori with triple 7-14 days and quadruple therapy in Turkey.;Gumurdulu;World J Gastroenterol,2004

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti‐Helicobacter pylori Infection Treatment and Pulmonary Hypersensitivity: Case Series and Review of the Literature;The Clinical Respiratory Journal;2024-08

2. Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days;Digestive Diseases and Sciences;2024-05-03

3. Independent risk factors predicting eradication failure of standard bismuth quadruple therapy for the first‐line treatment of Helicobacter pylori infection in Taiwan;Advances in Digestive Medicine;2024-04-11

4. Efficacy and tolerability of Helicobacter pylori eradication regimes in South Kivu, Eastern of the Democratic Republic of Congo: A single center observational study;Health Science Reports;2024-03

5. Helicobacter pylori: A Contemporary Perspective on Pathogenesis, Diagnosis and Treatment Strategies;Microorganisms;2024-01-22